Company / Current Assets per Share
Monte Rosa Therapeutics, Inc. Current Assets per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$5.11
FY2024
5-year range
$4.60 / $28.74
FY2020-FY2024
Trend
+11.1%
vs FY2023
Sector context
#131 of 210
Health Care
What the data says
At $5.11, Monte Rosa Therapeutics, Inc.'s current assets per share ranks #131 of 210 in the Health Care sector. Current Assets per Share returned to growth in FY2024 after 3 years of decline, reaching $5.11.
Based on SEC 10-K filings.
5.11 in FY2024 with a 3-year CAGR of -28.5%.
Declined from $5.84 to $5.11 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -28.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#131 of 210 in Health CareTop 62% of 210This company $5.11 Sector average $170.65
▼
-97.0% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 11.1% year-over-year.
- Ranks #131 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.11 | +11.1% |
| FY2023 | $4.60 | -21.3% |
| FY2022 | $5.84 | -58.1% |
| FY2021 | $13.95 | -51.5% |
| FY2020 | $28.74 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026